The past few months in the marijuana stock market have been extremely instrumental to the growth of the space as a whole. For some time now, the cannabis market has been gaining propensity toward the future with a series of new listings and a constant fight for new laws that go in line with what the people want to see. In that time, however, there have been several market corrections and general aspects of the industry that have scared some out of investing. Although the industry is quite volatile, this is extremely characteristic of such a new and speculative space and remains one of the most interesting reasons to invest in the cannabis space.

Scythian Biosciences Corp. (SCCYF/SCYB) has been one of the primary players in the biomedical research side of the cannabis industry for some time now. The company made headlines recently after naming Brady Cobb as CEO. Cobb prior, worked for the massive cannabis business, Liberty Health Sciences through the middle of the year, and has since been working to bring cannabis to the forefront of the country in the U.S. The company has also been working as one of many, to begin a series of acquisitions that have been aimed at boosting the synergy of the industry altogether. The company is based out of Vancouver and has been around for over 10 years, but only in recent times have they begun their venture into the U.S. market with goals set on the international industry in the future as well. Scythian has also been working with various research universities throughout the U.S. to help bring more research and development to the whole of the field. By working in the cutting edge, Scythian remains one of the interesting companies to watch as we move throughout the future.

MedMen Enterprises (NASDAQOTH:MMNFF) has been stated to be one of the larger retailers of cannabis in the U.S., with a very solid amount of exposure to some of the largest domestic markets in the whole of the industry. The company saw gains throughout October of around 30% which made them one of the companies to watch as the market moves on. In recent times, MedMen decided to purchase the company PharmaCann for almost $700 million during the middle of October. This cemented the largest cannabis deal in the U.S. in the history of the industry. MedMen has been working to have their retail locations become the most prolific way to purchase cannabis in the whole of the market. The company has been targeting the higher end of the marijuana space as well, working to gain the most money per square foot of retail space in their locations. This has become overwhelmingly positive as the company took in around $40 million in full-year sales which shows that they are up over 1,400% year over year. MedMen remains one of the most important stocks to keep an eye on throughout the coming years in the marijuana stock space.

Marijuana stocks continue to astound investors with their massive potential for the future. The only issue now that remains is that of legislation, but as more individuals show their support, it looks like this may be on the way out as well.

Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Scythian Biosciences, Midam is being paid $90,000 for a period of 3 months beginning August 29, 2018, and ending November 29, 2018. We own 0 shares of Scythian Biosciences. We may buy or sell additional shares of (SCCYF/SCYB) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Scythian Biosciences. Click Here For Full, Updated Disclaimer

The marijuana stock market has managed to be one of the more confusing markets to participate in if one doesn’t know the ins and outs of how an infant industry works. In the last several months, we’ve seen a vast increase in the amount of interested investors within the space. This has helped to bring in some needed capital to the cannabis market, but in turn has ended up making the industry more speculative than ever. Although this can be a good thing at times, speculative trading has managed to make the marijuana stock market have large fluctuations which has turned some investors off in recent times. With the passing of Canadian legislation to make recreational cannabis legal, it seems as though we are entering a new era where marijuana stocks can be invested in safely without the threat of these massive price swings.

Scythian Biosciences Corp. (SCCYF/SCYB) is “a pre-clinical research and development company that is in the process of developing drug therapies.” The company is based out of Canada which puts them at the perfect exposure to one of the largest legal cannabis markets in the world. In recent times, the company made headlines after investing $88 million in “Class B units in Verano Holdings, LLC (“Verano”), a private, Delaware organized, vertically integrated, licensed operator of cannabis cultivation, manufacturing and retail facilities across six key U.S. states and Puerto Rico.” The hopes are that this will help to expand their horizon into not only how they can produce various products, but how they can begin to create various distribution channels into the future. The company has also stated that they have agreed to sell 100% interest in 3 Boys Farms LLC, which will help the two build more capital as they move toward the future of the industry.

Aphria (NASDAQOTH:APHQF) has been one of the main growers of cannabis for the whole of the cannabis market. When they are at full capacity, they are subject to be able to grow as much as 255,000 kilograms of cannabis per year. The company also have two extremely large facilities which are aimed at producing the highest quality, and highest yields possible. The company has also stated that they have the ability to generate as much as 437% in fiscal growth throughout next year. This is in combination with the 180% they are scheduled to grow by the end of the 2020 fiscal year. All in all, Aphria remains one of the pure-play cannabis companies with the highest amount of value for the coming year and beyond.

Cannabis as a whole has remained a tricky space to invest in for some time now. As the market continues to mature over the course of the next few years, hopefully the issues with stability will be able to pan out. This will likely help to bring in a whole new slew of investors willing to take part in one of the most exciting industries of the modern day. Until then, it seems to be a waiting game as to when the market can see its true value reflected in the prices of the most popular businesses.

Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Scythian Biosciences, Midam is being paid $90,000 for a period of 3 months beginning August 29, 2018, and ending November 29, 2018. We own 0 shares of Scythian Biosciences. We may buy or sell additional shares of (SCCYF/SCYB) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Scythian Biosciences.